Attached files
| file | filename |
|---|---|
| EX-31 - EX-31 - NewGen BioPharma Corp. | ex-31.htm |
| EX-21 - EX-21 - NewGen BioPharma Corp. | ex-21.htm |
| EXCEL - IDEA: XBRL DOCUMENT - NewGen BioPharma Corp. | Financial_Report.xls |
| 10-K - FROM 10-K - NewGen BioPharma Corp. | grwd-10k_2013oct31.htm |
EXHIBIT 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Greenwind NRG Inc. (the “Company”) on Form 10-K for the period ended October 31, 2013, as filed with the Securities and Exchange Commission (the “Report”), each of the undersigned officers, certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: February 12, 2014
|
/s/ Jerwin Alfiler |
|
Jerwin Alfiler |
|
President, Secretary, Treasurer |
|
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |